What is Infinity, A Stamford Technology Company?
Infinity, A Stamford Technology Company, operates as a pivotal service provider for the biotech, pharmaceutical, and medical device industries. The firm specializes in delivering enterprise-grade IT solutions, including Argus Safety Services and Electronic Quality Management Systems (EQMS). By integrating custom web and cloud application development, Infinity enables its clients to navigate complex regulatory environments while maintaining high levels of operational efficiency.
The company's value proposition lies in its ability to bridge the gap between technical innovation and strict compliance requirements. Through the deployment of automation and tailored service models, Infinity supports organizations across the entire product development lifecycle. This focus on quality and collaboration has established the firm as a critical partner for entities ranging from emerging start-ups to established global pharmaceutical leaders.
How much funding has Infinity, A Stamford Technology Company raised?
Infinity, A Stamford Technology Company has raised a total of $403K across 2 funding rounds:
Debt
$150K
Debt
$253K
Debt (2020): $150K with participation from PPP
Debt (2021): $253K led by PPP
Key Investors in Infinity, A Stamford Technology Company
PPP
Public-Private Partnership
What's next for Infinity, A Stamford Technology Company?
With the successful closure of this late-stage funding round, Infinity is poised to accelerate its strategic growth initiatives. The capital will likely be deployed to deepen the company's technological moat, specifically through the enhancement of its automation capabilities and the expansion of its cloud-native service offerings. As the life sciences industry continues to prioritize digital transformation, Infinity is strategically aligned to capture increased market share by providing the infrastructure necessary for rapid, compliant innovation.
Looking ahead, the firm is expected to focus on scaling its service delivery models to accommodate a broader international client base. By leveraging its recent financial backing, Infinity aims to solidify its reputation as a premier provider of enterprise IT solutions, ensuring that its clients can effectively manage the complexities of modern drug and device development.
